---
document_datetime: 2023-09-21 18:40:38
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/rixubis-epar-all-authorised-presentations_en.pdf
document_name: rixubis-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0460678
conversion_datetime: 2025-12-24 01:05:59.795414
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA(EU) Number   | (Invented) name   | Strength   | Pharmaceutical Form                           | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size   |
|-----------------|-------------------|------------|-----------------------------------------------|---------------------------|-----------------------|---------------------------|-------------|
| EU/1/14/970/001 | Rixubis           | 250 IU     | Powder and solvent for solution for injection | Intravenous use           | vial (glass)          | 250 IU 5 ml (50 IU/ml)    | 1 vial      |
| EU/1/14/970/002 | Rixubis           | 500 IU     | Powder and solvent for solution for injection | Intravenous use           | vial (glass)          | 500 IU 5 ml (100 IU/ml)   | 1 vial      |
| EU/1/14/970/003 | Rixubis           | 1000 IU    | Powder and solvent for solution for injection | Intravenous use           | vial (glass)          | 1000 IU 5 ml (200 IU/ml)  | 1 vial      |
| EU/1/14/970/004 | Rixubis           | 2000 IU    | Powder and solvent for solution for injection | Intravenous use           | vial (glass)          | 2000 IU 5 ml (400 IU/ml)  | 1 vial      |
| EU/1/14/970/005 | Rixubis           | 3000 IU    | Powder and solvent for solution for injection | Intravenous use           | vial (glass)          | 3000 IU 5 ml (600 IU/ml)  | 1 vial      |